we do not suggest that all patients with RA and SjD be screened for ILD, we suggest screening at presentation in those with ILD risk factors such as those specified in, but not limited to, Table 1 Monitoring for ILD progression Although screening for ILD in people with SARDs is largely the purview of rheumatologists, the monitoring of patients with identified SARD-associated ILD is expected to be a multidisciplinary collaboration between rheumatology and pulmonology. Thus, some recommendations